GMP Close-out Letter Program Shows Few Benefits After 20 Months

More than 20 months after FDA Commissioner Margaret Hamburg announced with much fanfare that the agency would issue "close-out letters" to companies that had received FDA warning letters once they had addressed the problems inspectors found, the program has yet to fulfill its promise of offering sponsors a reliable, public way of resolving regulatory problems.